Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

Trading update

25 Oct 2021 07:00

RNS Number : 0283Q
Fisher (James) & Sons plc
25 October 2021
Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

25 October 2021

James Fisher and Sons plc

Trading update

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group'), the leading marine service provider, today publishes a trading update.

Β· Following a difficult start to the year, improvement in the Fendercare ship-to-ship transfer business remains below the rate previously expected, with some growing evidence of market shifts in some key territories.

Β· JFD has reached an impasse in negotiations over c.Β£2m due on a long-term project and is no longer forecasting a resolution in 2021.

Β· Customers of the Group's Marine Contracting, Decommissioning and Nuclear businesses have further delayed projects in recent weeks. The projects were previously expected to commence, and in some cases finish, in 2021. The continuing challenges presented by the global pandemic, particularly in the safe mobilisation of teams to work sites, have influenced customer decision-making processes.

Β· A recent deterioration in the condition of a financially distressed customer has increased bad debt risk by c.Β£2m.

Β· Tankships experienced a poor month in September and as a result has a more cautious outlook for the full year.

Β· Revenue in the quarter ended 30 September 2021 was 7.6% higher than Q3 2020 and 8.7% higher than Q2 of 2021. Year to date revenue is 3.9% below prior year.

Β· The Board now anticipates Underlying Operating Profit for the full year, before separately disclosed items, to be in the range of Β£27m - Β£32m.

The Group continues to trade within its banking covenants (which are formally measured at each half year end) and at 30 September had headroom of c.Β£100m against its revolving credit facilities.

In response to the latest short-term trading outlook, management is performing a detailed review of the Group's cost base and balance sheet. Aligned with the Board's commitment to 'fix or exit' non-core and underperforming businesses, the Group is continuing to advance at pace the divestment of non-core businesses and assets aimed at generating significant proceeds over the next year, to reduce net debt and financial leverage as well as to simplify the business.

Notwithstanding some revenue opportunity moving from Q4 2021 to 2022, the Board currently expects this to be materially offset by the continuation of challenges the Group is currently experiencing with customer demand and the safe mobilisation of teams to work sites.

The Board remains confident in the Group's strategy to deliver sustainable profitable growth from the significant market opportunities that are available to it and remains committed to executing on its long-term strategy.

Divisional Summary

Marine Support

The Fendercare ship-to-ship transfer business has continued to improve, but still not at the rate previously expected. There is growing evidence of market shifts in some key territories and the management team is conducting a detailed review of locations and trading partners to ensure that the business has the optimal mix of each.

Marine Contracting is trading ahead of prior year but has suffered from recent customer and weather delays that have pushed projects into H1 2022. Within our Renewables franchise EDS, the high voltage specialist, continues to perform well and has recently signed two multi-year, multi-million pound contracts with tier 1 contractors for monitoring services in Northern Europe, and more of these contracts remain in the sales pipeline. There has been no material change in the situation in Mozambique. The LNG projects remain suspended and dispute resolution discussions with our clients are ongoing. The Digital and Data Services businesses are in line with expectations and have strong order books.

Offshore Oil

The ScanTech businesses continue to perform well, showing strong growth over 2020 as demand for well-testing services, compressors and other asset rentals continues. ScanTech's bubble curtain offering to the Renewables market is continuing to see high demand with YTD revenue twice that achieved in the same period of 2020. RMSpumptools remains in line with expectations. The James Fisher Offshore business has experienced multiple delays to awarded projects and, following a recent deterioration in the condition of a financially distressed customer has increased bad debt risk of c.Β£2m. The most recent example being a customer delaying a multi-million dollar decommissioning project scheduled for Q4 2021 into 2022. Although frustrating, the order book is strong and demand for decommissioning services continues to show growth.

Specialist Technical

JFD's short-cycle diving equipment and training revenues remain soft, as previously announced, and are expected to remain so until well into 2022. In addition, the business has reached an impasse in negotiations over c.Β£2m due on a long-term project and is no longer forecasting a resolution in 2021.

The nuclear decommissioning business is in line with expectations at the end of Q3, however a major customer has unexpectedly deferred the award of new projects planned for Q4 2021 into 2022, leaving JFN with a shortfall for the remainder of the year. The business is focusing on short-term cost saving measures to mitigate the impact.

Tankships

Following a consistent trend of improvements in trading from February to August, the Tankships division experienced lower volumes of cargo and subdued market spot rates in September. It is not expected that the business will be able to recover the September shortfall and management has a more cautious outlook for the remainder of the year.

Group Revenue (unaudited)

Β£m

2020

2021

Quarter on quarter

variance

Cumulative variance

Q1

129.4

109.3

-15.5%

-15.5%

Q2

128.7

124.4

-3.3%

-9.5%

Q3

125.7

135.2

+7.6%

-3.9%

Q4

134.4

Β 

Β 

Β 

Β 

For further information

James Fisher and Sons plc

Eoghan O'Lionaird

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9508

FTI Consulting

Richard Mountain

Β 

020 3727 1340

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTPPGGGUUPGPGC
Date   Source Headline
21st Apr 20209:00 amRNSHolding(s) in Company
15th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 202010:20 amRNSDirector/PDMR Shareholding
1st Apr 20204:35 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSAnnual General Meeting and COVID-19
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSCovid-19 Update
20th Mar 20205:30 pmRNSAnnual Report and Accounts posted
20th Mar 20204:45 pmRNSDirector/PDMR Shareholding
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSDirectorate Change
18th Mar 202012:02 pmRNSPrice Monitoring Extension
18th Mar 202010:21 amRNSFinal dividend payment date
17th Mar 20203:57 pmRNSDirector/PDMR Shareholding
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20204:41 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSFinal Results for the year ended 31 December 2019
21st Feb 20207:00 amRNSFour year contract extension worth £35m
13th Feb 202012:51 pmRNSDirector Shareholding Update
16th Jan 20203:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jan 202012:07 pmRNSSecond Price Monitoring Extn
9th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202011:06 amRNSDirector/PDMR Shareholding
2nd Jan 202011:19 amRNSTotal Voting Rights
6th Dec 20199:35 amRNSTotal Voting Rights and Share Capital
28th Nov 20197:00 amRNSTrading Update
5th Nov 20191:29 pmRNSNotice of cyber security incident
2nd Oct 201911:39 amRNSTotal Voting Rights and Share Capital
1st Oct 20197:00 amRNSCONFIRMATION OF APPOINTMENT OF CEO
27th Sep 20197:00 amRNSSubmarine Rescue System contract
4th Sep 20192:38 pmRNSTotal Voting Rights
28th Aug 20197:00 amRNSHalf year results
7th Aug 20197:00 amRNSAcquisition of SM Continental S.A.
16th Jul 20197:00 amRNSContract Wins
5th Jul 20197:00 amRNSAppointment of new Chief Executive Officer
1st Jul 20199:49 amRNSTotal Voting Rights
19th Jun 201911:13 amRNSBLOCK LISTING SIX MONTHLY RETURN
10th Jun 20197:00 amRNSAdditional Listing
2nd May 20194:20 pmRNSResult of AGM
2nd May 20197:00 amRNSTrading Update & AGM Statement
26th Apr 20191:59 pmRNSDirector/PDMR Shareholding
18th Apr 20191:07 pmRNSDirector/PDMR Shareholding
10th Apr 20194:32 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:30 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:28 pmRNSNotification of Directors' Interest in Shares
10th Apr 20194:25 pmRNSNotification of Directors' Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.